Here's the Deal
Baird's Investment Banking Group is pleased to announce the following transaction:
Sale to Great Hill Partners and Primus Capital Funds
Baird served as the exclusive financial advisor to SterilMed, Inc. on this transaction
SterilMed, Inc. (“SterilMed” or the “Company”) recently completed its sale to Great Hill Partners and Primus Capital Funds. SterilMed was backed by a group of private equity investors including Ascension Health Ventures, First Analysis, Prism Capital and Sterling Partners. Terms of the transaction were not disclosed.
SterilMed offers services designed to help healthcare providers lower their medical device and equipment costs by maximizing the life of “single-use” medical devices, surgical instruments, power tools, endoscopes and video equipment. This allows healthcare facilities to free up critical financial resources through better device and equipment utilization while maintaining the highest levels of patient safety. The Company takes a uniquely integrated approach to medical device reprocessing that ensures the most streamlined logistics and the most rigorous quality approach enabling hospitals and medical facilities to reduce device cost and to decrease medical waste. SterilMed has saved healthcare providers hundreds of millions of dollars and thousands of tons of medical waste from landfills over the past few years.
Great Hill Partners is a private equity firm that manages over $2.5 billion in capital to finance the expansion, recapitalization or acquisition of growth companies in a wide range of sectors within the business and consumer services, healthcare, media, communications and software industries.
Primus Capital Funds is a private equity firm that invests in high-growth companies within the healthcare, business services, and for-profit education industry sectors. Transaction types include management-led buyouts, recapitalizations, and primary investments of growth capital.